You have free access to this content

Hepatology

Cover image for Vol. 46 Issue 3

September 2007

Volume 46, Issue 3

Pages 611–952

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Hepatitis C virus and human immunodeficiency virus: The Un-Won Battle (pages 611–614)

      Javier García-Samaniego and Xavier Forns

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21818

    2. You have free access to this content
      New therapies for hepatitis C (pages 615–617)

      Apurva A. Modi and Jay H. Hoofnagle

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21892

    3. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy (pages 622–630)

      Juan A. Pineda, José A. García-García, Manuela Aguilar-Guisado, María J. Ríos-Villegas, Josefa Ruiz-Morales, Antonio Rivero, José del Valle, Rafael Luque, Jesús Rodríguez-Baño, Mercedes González-Serrano, Angela Camacho, Juan Macías, Israel Grilo and Jesús M. Gómez-Mateos

      Version of Record online: 20 JUL 2007 | DOI: 10.1002/hep.21757

    2. You have free access to this content
      Telaprevir and pegylated interferon–alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients (pages 631–639)

      Tara L. Kieffer, Christoph Sarrazin, Janice S. Miller, Martin W. Welker, Nicole Forestier, Hendrik W. Reesink, Ann D. Kwong and Stefan Zeuzem

      Version of Record online: 6 AUG 2007 | DOI: 10.1002/hep.21781

    3. You have free access to this content
      Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C (pages 640–648)

      Nicole Forestier, Hendrik W. Reesink, Christine J. Weegink, Lindsay McNair, Tara L. Kieffer, Hui-May Chu, Susan Purdy, Peter L.M. Jansen and Stefan Zeuzem

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21774

    4. You have free access to this content
      Proteomic profiling of human liver biopsies: Hepatitis C virus–induced fibrosis and mitochondrial dysfunction (pages 649–657)

      Deborah L. Diamond, Jon M. Jacobs, Bryan Paeper, Sean C. Proll, Marina A. Gritsenko, Robert L. Carithers Jr., Anne M. Larson, Matthew M. Yeh, David G. Camp II, Richard D. Smith and Michael G. Katze

      Version of Record online: 25 JUL 2007 | DOI: 10.1002/hep.21751

    5. You have free access to this content
      Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C (pages 658–665)

      Maïté Lewin, Armelle Poujol-Robert, Pierre-Yves Boëlle, Dominique Wendum, Elisabeth Lasnier, Magalie Viallon, Jérôme Guéchot, Christine Hoeffel, Lionel Arrivé, Jean-Michel Tubiana and Raoul Poupon

      Version of Record online: 30 JUL 2007 | DOI: 10.1002/hep.21747

    6. You have free access to this content
      Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000 (pages 666–671)

      Fan-Chen Tseng, Thomas R. O'Brien, Mingdong Zhang, Alex H. Kral, Betty A. Ortiz-Conde, Jennifer Lorvick, Michael P. Busch and Brian R. Edlin

      Version of Record online: 26 JUL 2007 | DOI: 10.1002/hep.21765

    7. You have free access to this content
      Transforming growth factor-β1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA (pages 672–681)

      Yu-Chi Chou, Mong-Liang Chen, Cheng-Po Hu, Ya-Ling Chen, Chin-Liew Chong, Yue-Lin Tsai, Tzu-Ling Liu, King-Song Jeng and Chungming Chang

      Version of Record online: 19 JUN 2007 | DOI: 10.1002/hep.21726

    8. You have free access to this content
      Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C (pages 682–689)

      Thomas F. Baumert, Christine Rösler, Michael H. Malim and Fritz von Weizsäcker

      Version of Record online: 11 JUL 2007 | DOI: 10.1002/hep.21733

    9. You have free access to this content
      Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients (pages 690–698)

      Chee-Kin Hui, Nancy Leung, Tony W.H. Shek, Hung Yao, Wai-Ki Lee, Jak-Yiu Lai, Sik-To Lai, Wai-Man Wong, Lawrence SW. Lai, Ronnie T.P. Poon, Chung-Mau Lo, Sheung-Tat Fan and George K.K. Lau

      Version of Record online: 6 AUG 2007 | DOI: 10.1002/hep.21758

    10. You have free access to this content
      Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus–specific immune response (pages 699–705)

      Jeroen N. Stoop, Andrea M. Woltman, Paula J. Biesta, Johannes G. Kusters, Ernst J. Kuipers, Harry L.A. Janssen and Renate G. van der Molen

      Version of Record online: 25 JUL 2007 | DOI: 10.1002/hep.21761

    11. You have free access to this content
  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Metabolic correlates of nonalcoholic fatty liver in women and men (pages 716–722)

      Gloria Lena Vega, Manisha Chandalia, Lidia S. Szczepaniak and Scott M. Grundy

      Version of Record online: 20 JUL 2007 | DOI: 10.1002/hep.21727

    2. You have free access to this content
      HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis (pages 723–729)

      James E. Nelson, Renuka Bhattacharya, Keith D. Lindor, Naga Chalasani, Stuart Raaka, E. Jenny Heathcote, Emil Miskovsky, Eldon Shaffer, Stephen J. Rulyak and Kris V. Kowdley

      Version of Record online: 6 AUG 2007 | DOI: 10.1002/hep.21742

    3. You have free access to this content
  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry (pages 740–748)

      Paulette Bioulac-Sage, Sandra Rebouissou, Cristel Thomas, Jean-Frédéric Blanc, Jean Saric, Antonio Sa Cunha, Anne Rullier, Gaëlle Cubel, Gabrielle Couchy, Sandrine Imbeaud, Charles Balabaud and Jessica Zucman-Rossi

      Version of Record online: 30 JUL 2007 | DOI: 10.1002/hep.21743

    2. You have free access to this content
      Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma (pages 749–758)

      Jian-Min Yuan, Shelly C. Lu, David Van Den Berg, Sugantha Govindarajan, Zhen-Quan Zhang, Jose M. Mato and Mimi C. Yu

      Version of Record online: 20 JUL 2007 | DOI: 10.1002/hep.21735

    3. You have free access to this content
      Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis (pages 759–768)

      Stephan Singer, Volker Ehemann, Antje Brauckhoff, Martina Keith, Sebastian Vreden, Peter Schirmacher and Kai Breuhahn

      Version of Record online: 30 JUL 2007 | DOI: 10.1002/hep.21736

  5. Autoimmune, Cholestatic, and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States (pages 769–775)

      Marion G. Peters, Adrian M. Di Bisceglie, Kris V. Kowdley, Nancy L. Flye, Velimir A. Luketic, Santiago J. Munoz, Guadalupe Garcia-Tsao, Thomas D. Boyer, John R. Lake, Maurizio Bonacini and Burton Combes

      Version of Record online: 25 JUL 2007 | DOI: 10.1002/hep.21759

    2. You have free access to this content
      Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid (pages 776–784)

      Tatjana Stojakovic, Csilla Putz-Bankuti, Günter Fauler, Hubert Scharnagl, Martin Wagner, Vanessa Stadlbauer, Gerald Gurakuqi, Rudolf E. Stauber, Winfried März and Michael Trauner

      Version of Record online: 1 AUG 2007 | DOI: 10.1002/hep.21741

    3. You have free access to this content
      Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis (pages 785–792)

      Konstantinos N. Lazaridis, Brian D. Juran, Gwen M. Boe, Joshua P. Slusser, Mariza de Andrade, Henry A. Homburger, Karthik Ghosh, E. Rolland Dickson, Keith D. Lindor and Gloria M. Petersen

      Version of Record online: 6 AUG 2007 | DOI: 10.1002/hep.21749

    4. You have free access to this content
      Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol (pages 793–801)

      Frank Grünhage, Monica Acalovschi, Simona Tirziu, Maja Walier, Thomas F. Wienker, Anca Ciocan, Ofelia Mosteanu, Tilman Sauerbruch and Frank Lammert

      Version of Record online: 11 JUL 2007 | DOI: 10.1002/hep.21847

  6. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection (pages 802–812)

      Xiaoling Jin, Zongxiu Zhang, Donna Beer-Stolz, Teresa A. Zimmers and Leonidas G. Koniaris

      Version of Record online: 1 AUG 2007 | DOI: 10.1002/hep.21728

    2. You have free access to this content
      Dispensability and dynamics of caveolin-1 during liver regeneration and in isolated hepatic cells (pages 813–822)

      Rafael Mayoral, Amalia Fernández-Martínez, Rosa Roy, Lisardo Boscá and Paloma Martín-Sanz

      Version of Record online: 25 JUL 2007 | DOI: 10.1002/hep.21746

    3. You have free access to this content
      Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes (pages 823–830)

      Swati Joshi-Barve, Shirish S. Barve, Kiranmayi Amancherla, Leila Gobejishvili, Daniell Hill, Matthew Cave, Prachi Hote and Craig J. McClain

      Version of Record online: 6 AUG 2007 | DOI: 10.1002/hep.21752

  7. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome (pages 831–840)

      Rajeshwar P. Mookerjee, Vanessa Stadlbauer, Sukhwinderjit Lidder, Gavin A.K. Wright, Stephen J. Hodges, Nathan A. Davies and Rajiv Jalan

      Version of Record online: 6 AUG 2007 | DOI: 10.1002/hep.21737

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis (pages 841–850)

      Julia Ewaschuk, Ryan Endersby, David Thiel, Hugo Diaz, Jody Backer, Mang Ma, Thomas Churchill and Karen Madsen

      Version of Record online: 20 JUL 2007 | DOI: 10.1002/hep.21750

    2. You have free access to this content
    3. You have free access to this content
      Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers (pages 861–870)

      Marc Brulport, Wiebke Schormann, Alexander Bauer, Matthias Hermes, Carolin Elsner, Friedrich Jakob Hammersen, Walter Beerheide, Dimitry Spitkovsky, Wolfgang Härtig, Andreas Nussler, Lars Christian Horn, Jeanett Edelmann, Oliver Pelz-Ackermann, Jörg Petersen, Manja Kamprad, Marc von Mach, Amelie Lupp, Henryk Zulewski and Jan G. Hengstler

      Version of Record online: 1 AUG 2007 | DOI: 10.1002/hep.21745

    4. You have free access to this content
      Receptor-mediated endocytosis of immune complexes in rat liver sinusoidal endothelial cells is mediated by FcγRIIb2 (pages 871–884)

      Seyed Ali Mousavi, Marita Sporstøl, Cathrine Fladeby, Rune Kjeken, Nicolas Barois and Trond Berg

      Version of Record online: 6 AUG 2007 | DOI: 10.1002/hep.21748

    5. You have free access to this content
      Insights in the regulation of cholesterol 7α-hydroxylase gene reveal a target for modulating bile acid synthesis (pages 885–897)

      Nico Mitro, Cristina Godio, Emma De Fabiani, Elena Scotti, Andrea Galmozzi, Federica Gilardi, Donatella Caruso, Ana Belen Vigil Chacon and Maurizio Crestani

      Version of Record online: 25 JUL 2007 | DOI: 10.1002/hep.21819

    6. You have free access to this content
      Pancreatic and duodenal homeobox gene 1 induces hepatic dedifferentiation by suppressing the expression of CCAAT/enhancer-binding protein β (pages 898–905)

      Irit Meivar-Levy, Tamar Sapir, Shiraz Gefen-Halevi, Vered Aviv, Iris Barshack, Nicholas Onaca, Eytan Mor and Sarah Ferber

      Version of Record online: 17 AUG 2007 | DOI: 10.1002/hep.21766

  9. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
    2. You have free access to this content
  10. AASLD Practice Guidelines

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis (pages 922–938)

      Guadalupe Garcia-Tsao, Arun J. Sanyal, Norman D. Grace and William Carey

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21907

  11. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
      N-acetylcysteine for acetaminophen overdose: When enough is enough (pages 939–941)

      Neeral L. Shah and Fredric D. Gordon

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21862

    2. You have free access to this content
    3. You have free access to this content
      The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: The missing piece? (pages 943–946)

      Rajeshwar P. Mookerjee, Balasubramaniyan Vairappan and Rajiv Jalan

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21905

  12. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content
    2. You have free access to this content
      Reply: (pages 947–949)

      Chih-Lin Lin, Chun-Jen Liu and Jia-Horng Kao

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21866

    3. You have free access to this content
    4. You have free access to this content
      Should impaired liver function be held responsible for cognitive impairment and poor health-related quality of life in alcoholic cirrhosis? (page 950)

      Thomas Paparrigopoulos, Elias Tzavellas, Dimitris Karaiskos and Ioannis Liappas

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21851

    5. You have free access to this content
      Reply: (page 951)

      Radha K. Dhiman, Ajay Duseja and Yogesh K. Chawla

      Version of Record online: 24 AUG 2007 | DOI: 10.1002/hep.21924

  13. Correspondences

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic, and Biliary Disease
    7. Liver Injury/Regeneration
    8. Liver Failure/Cirrhosis/Portal Hypertension
    9. Liver Biology/Pathobiology
    10. Reviews
    11. AASLD Practice Guidelines
    12. Hepatology Elsewhere
    13. Correspondence
    14. Correspondences
    1. You have free access to this content

SEARCH

SEARCH BY CITATION